1. Home
  2. WGRX vs RFL Comparison

WGRX vs RFL Comparison

Compare WGRX & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGRX
  • RFL
  • Stock Information
  • Founded
  • WGRX 2022
  • RFL 2017
  • Country
  • WGRX United States
  • RFL United States
  • Employees
  • WGRX N/A
  • RFL N/A
  • Industry
  • WGRX Other Pharmaceuticals
  • RFL Real Estate
  • Sector
  • WGRX Health Care
  • RFL Finance
  • Exchange
  • WGRX Nasdaq
  • RFL Nasdaq
  • Market Cap
  • WGRX 60.2M
  • RFL 54.4M
  • IPO Year
  • WGRX 2025
  • RFL N/A
  • Fundamental
  • Price
  • WGRX $0.55
  • RFL $1.22
  • Analyst Decision
  • WGRX
  • RFL
  • Analyst Count
  • WGRX 0
  • RFL 0
  • Target Price
  • WGRX N/A
  • RFL N/A
  • AVG Volume (30 Days)
  • WGRX 2.3M
  • RFL 86.8K
  • Earning Date
  • WGRX 11-19-2025
  • RFL 12-10-2025
  • Dividend Yield
  • WGRX N/A
  • RFL N/A
  • EPS Growth
  • WGRX N/A
  • RFL N/A
  • EPS
  • WGRX N/A
  • RFL N/A
  • Revenue
  • WGRX $34,077,635.00
  • RFL $917,000.00
  • Revenue This Year
  • WGRX N/A
  • RFL N/A
  • Revenue Next Year
  • WGRX N/A
  • RFL N/A
  • P/E Ratio
  • WGRX N/A
  • RFL N/A
  • Revenue Growth
  • WGRX 495.93
  • RFL 43.96
  • 52 Week Low
  • WGRX $0.34
  • RFL $1.19
  • 52 Week High
  • WGRX $7.04
  • RFL $3.19
  • Technical
  • Relative Strength Index (RSI)
  • WGRX 46.02
  • RFL 30.42
  • Support Level
  • WGRX $0.44
  • RFL $1.19
  • Resistance Level
  • WGRX $0.71
  • RFL $1.29
  • Average True Range (ATR)
  • WGRX 0.07
  • RFL 0.06
  • MACD
  • WGRX 0.00
  • RFL -0.00
  • Stochastic Oscillator
  • WGRX 44.15
  • RFL 7.69

About WGRX Wellgistics Health Inc. Common Stock

Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Share on Social Networks: